Cyclopentenone prostaglandins: New insights on biological activities and cellular targets

Medicinal Research Reviews

Volumn 21, Issue 3, 2001, Pages 185-210

  Straus, Daniel S ^a   Glass, Christopher K ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

15 deoxy 12,14 PGJ2; And anti viral activities; Anti inflammatory; Anti neoplastic; Cyclopentenone prostaglandins PGA2; I B kinase; Nuclear factor B; Peroxisome proliferator activated receptor ; PGA1; PGJ2

Indexed keywords

CARBONYL DERIVATIVE; CELL NUCLEUS RECEPTOR; CYCLOPENTENONE DERIVATIVE; CYLCOPENTENONE PROSTAGLANDIN; GUANINE NUCLEOTIDE BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSTAGLANDIN A1; PROSTAGLANDIN A2; PROSTAGLANDIN D2; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN E1; PROSTAGLANDIN E2; PROSTAGLANDIN J2; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; APOPTOSIS; BINDING AFFINITY; CELL CYCLE; CELL TYPE; DEHYDRATION; DRUG ACTIVITY; DRUG POTENCY; GENETIC TRANSCRIPTION; LIGAND BINDING; MITOSIS INHIBITION; PROTEIN BINDING; REVIEW;

ANIMALS; CYCLOPENTANES; HUMANS; PROSTAGLANDINS;

EID: 0035053973     PISSN: 01986325     EISSN: None     Source Type: Journal    
DOI: 10.1002/med.1006     Document Type: Review

References (162)

1. Prostaglandin and thromboxane biosynthesis
2. Function and regulation of prostaglandin synthase 2
3. Prostaglandins in human seminal plasma. Prostaglandins and related factors 46
4. 2 from rabbit kidney medulla
5. Renomedullary vasodepressor substance, medulin: Isolation, chemical characterization and physiological properties
6. 1 in essential hypertension
7. 1
8. 2 derivative with potent antineoplastic and weak smooth muscle-contracting activities
9. 2-anti-tumour and anti-viral activities and mechanisms involved
10. 4,6]oct-7-en-3-one with a cuprate reagent
11. 2. Identification of products formed in vitro
12. 2 formed in human plasma
13. 2
14. 2 and its analogues
15. 2 is a ligand for the adipocyte determination factor PPARγ
16. 2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation
17. 2 in pharmaceutical preparations by ion-pair reversed phase HPLC
18. Endogenous prostaglandins A's (PGAs): Fact or artifact in biological systems
19. 2 in human plasma by gas chromatography-mass spectrometry
20. High performance liquid chromatography of prostaglandins: Biological applications
21. 2 from plasma using deuterated carrier and gas-liquid chromatography-mass spectrometry
22. 2-analogue sulprostone in human plasma, and isolation from urine (in vivo) and liver perfusate (in vitro) of female guinea-pigs
23. Prostaglandin biosynthesis by rabbit renomedullary interstitial cells in tissue culture. Stimulation by angiotensin II, bradykinin, and arginine vasopressin
24. Prostaglandin synthesis in rat adrenocortical cells
25. Prostaglandin synthesis in human T cells: Its partial inhibition by lectins and anti-CD3 antibodies as a possible step in T cell activation
26. Rapid quantification of 11 prostanoids by combined capillary column gas chromatography and negative ion chemical ionization mass spectrometry: Application to prostanoids released from normal human embryonic lung fibroblasts W138 in a culture medium
27. 2α by decidual stromal cells and macrophages in culture
28. 1 in human peripheral blood
29. 1 in sera
30. 2 in human urine
31. 2 by murine mast cells: Importance of metabolite formation for antiproliferative activity
32. Inducible cyclooxygenase may have anti-inflammatory properties
33. Structures, properties and distribution of prostanoid receptors
34. Characterization of the recombinant human prostanoid DP receptor and identification of L644,698, a novel selective DP agonist
35. 1 and glutathione catalyzed by homogeneous glutathione-S-transferases from human and rat liver
36. Requirement of a reactive α,β-unsaturated carbonyl for inhibition of tumor growth and induction of differentiation by "A" series prostaglandins
37. 2
38. 2 with intracellular glutathione and enhancement of its anti-proliferative activity by glutathione depletion
39. 2-glutathione conjugate in L1210 mouse leukemia cells
40. The glutathione S-transferase supergene family: Regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance
41. 2 with glutathione, catalyzed by the human glutathione S-transferases Al-1, A2-2, Mla-1a, and Pl-1
42. 2 with the glutathione-mediated biotransformation system
43. Organic synthesis of prostaglandins: Advancing biology
44. Induction of MRP/GS-X pump and cellular resistance to anticancer prostaglandins
45. Transport of glutathione prostaglandin A conjugates by the multidrug resistance protein 1
46. Anti-cancer-prostaglandin-induced cell-cycle arrest and its modulation by an inhibitor of the ATP-dependent glutathione S-conjugate export pump (GS-X pump)
47. 2
48. Effects of cyclopentenone prostaglandins and related compounds on insulin-like growth factor-I and Waf1 gene expression
49. 2-Cyclopenten-1-one, a new inducer of heat shock protein 70 with antiviral activity
50. 2 inhibits multiple steps in the NF-κB signaling pathway
51. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IKB kinase
52. The generation and actions of isoprostanes
53. 2) in vivo
54. Formation of reactive cyclopentenone compounds in vivo as products of the isoprostane pathway
55. 2 cross-links proteins
56. 2
57. 2 via the levuglandin pathway
58. 2, a product of the isoprostane pathway, in oxidized low density lipoprotein
59. The logic of chemical synthesis-multistep synthesis of complex carbogenic molecules
60. Three component coupling synthesis of prostaglandins. A simplified, general procedure
61. Peroxisome proliferator-activated receptor-α activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis
62. Peroxisome proliferator-activated receptor-γ: A versatile metabolic regulator
63. The peroxisome proliferator-activated receptor (PPARγ) as a regulator of monocyte/macrophage function
64. Roles of PPARs in health and disease
65. Transcriptional regulation of adipogenesis
66. Ligand binding and coactivator assembly of the peroxisome proliferator-activated receptor-γ
67. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ
68. Molecular recognition of fatty acids by peroxisome proliferator-activated receptors
69. Differential activation of peroxisome proliferator-activated receptors by eicosanoids
70. The coregulator exchange in transcriptional functions of nuclear receptors
71. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
72. Peroxisome proliferator-activated receptor γ-dependent repression of the inducible nitric oxide synthase gene
73. Fos is a preferential target of glucocorticoid receptor inhibition of AP-1 activity in vitro
74. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors
75. 2: A growth-dependent response mediated by activation of heat shock transcription factor
76. Antiproliferative prostaglandins activate heat shock transcription factor
77. Heat shock factors and the control of stress response
78. Induction of thermotolerance by prostaglandin A in human cells
79. 1 in human monocytes. Evidence for transcriptional and post-transcriptional regulation
80. Regulation of BiP gene expression by cyclopentenone prostaglandins through unfolded protein response element
81. Localization of a cyclopentenone prostaglandin to the endoplasmic reticulum and induction of BiP mRNA
82. 2 results in elevated expression of gadd153 mRNA
83. 2
84. 2 specifically represses IGF-I gene expression in C6 rat glioma cells
85. 2-induced growth arrest
86. 2
87. 1 of heme oxygenase in myoblastic cells: An effect independent of expression of the 70 kDa heat shock protein
88. 2-induced expression of the rat heme oxygenase gene
89. 2-induced expression of rat heme oxygenase-1 gene
90. 2 in L-1210 cells
91. 2-induced expression of glutathione S-transferases
92. 2 on c-myc expression and cell cycle progression in human leukemia cell line HL-60
93. 1 phase by prostaglandins
94. Tripartite management of unfolded proteins in the endoplasmic reticulum
95. Depletion of intracellular calcium stores by calcium ionophore A23187 induces the genes for glucose-regulated proteins in hamster fibroblasts
96. The regulation of AP-1 activity by mitogen-activated protein kinases
97. Regulation and function of the JNK subgroup of MAP kinases
98. PPARγ agonists inhibit production of monocyte inflammatory cytokines
99. 2
100. NF-κB and rel proteins: Evolutionarily conserved mediators of immune responses
101. Phosphorylation meets ubiquitination: The control of NF-κB activity
102. 1: An effect associated with heat shock transcription factor activation
103. 2 in activated murine macrophages
104. The RxxRxRxxC motif conserved in all Rel/κB proteins is essential for the DNA-binding activity and redox regulation of the v-Rel oncoprotein
105. N-terminal DNA-binding domains contribute to differential DNA-binding specificities of NF-κB p50 and p65
106. Cloning and crystal structure of hematopoietic prostaglandin D synthase
107. Prostaglandin D2 synthase: Structure and function
108. Growth of Madin-Darby canine kidney epithelial cell (MDCK) line in hormone-supplemented, serum-free medium
109. 1 requirement for MDCK cell growth associated with a defect in cyclic AMP phosphodiesterase
110. 2α
111. 2α to regulate initiation of DNA replication and cell division in Swiss 3T3 cells
112. Change in growth and morphology of fibroblasts by prostaglandins
113. Fatty acids and their prostaglandin derivatives: Inhibitors of proliferation in aortic smooth muscle cells
114. 1
115. Prostaglandin analogs as inhibitors of tumor cell DNA synthesis
116. Evidence for cAMP-independent inhibition of S-phase DNA synthesis by prostaglandins
117. Effects of bradykinin on DNA synthesis in resting NIL8 hamster cells and human fibroblasts
118. Inhibition of tumor growth in vivo and in vitro by prostaglandin E
119. 2 regulated expression of type I collagen α1, lysyl oxidase, and cyclooxygenase-1 genes in human embryo lung fibroblasts
120. Requirement of a reactive α,β-unsaturated carbonyl for inhibition of tumor growth and induction of differentiation by "A" series prostaglandins
121. 2-induced growth inhibition
122. 2, a potential antineoplastic agent
123. Synthesis of new antineoplastic prostaglandins
124. 2 in vitro and in vivo
125. 1 arrest and preclinical results
126. Preclinical studies of antitumor prostaglandins by using human ovarian cancer cells
127. 1-methyl ester integrated into lipid microspheres against human ovarian carcinoma cells resistant to cisplatin in vivo
128. 1 analogues
129. Rational design of antitumor prostaglandins with high biological stability
130. 2
131. 2 in human P1-21 myeloid leukemia and RC-K8 pre-B lymphoma cells
132. 2 in transformed endothelial cells
133. 2
134. 2
135. 2-mediated cellular arrest and death
136. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death
137. Akt suppresses apoptosis by stimulating the transactivation potential of the Re1A/p65 subunit of NF-κB
138. Adjuvant effects of antineoplastic prostaglandins to cisplatin in nude mice bearing human ovarian cancer cells
139. 2 is cytotoxic in human malignancies and synergizes with both cisplatin and radiation
140. Prostaglandins in the treatment of cancer
141. 1-methyl ester integrated into lipid microspheres against human ovarian carcinoma cells resistant to cisplatin in vivo
142. Prostaglandin A compounds as antiviral agents
143. 2
144. 1 on herpes simplex virus and human immunodeficiency virus replication
145. Antiviral effect of prostaglandins of the A series: Inhibition of vaccinia virus replication in cultured cells
146. Suppression of virus replication by prostaglandin A is associated with heat shock protein synthesis
147. Antiviral activity of a synthetic analog of prostaglandin A in mice infected with influenza A virus
148. Antiviral activity of prostaglandin A on encephalomyocarditis virus-infected cells: A unique effect unrelated to interferon
149. Inhibition of poliovirus replication by prostaglandins A and J in human cells
150. Inhibition of Sindbis virus replication by cyclopentenone prostaglandins: A cell-mediated event associated with heat shock protein synthesis
151. 1
152. Prostaglandin A inhibits replication of human immunodeficiency virus during acute infection
153. Inhibition of HIV-1 replication by cyclopentenone prostaglandins in acutely infected human cells. Evidence for a transcriptional block
154. Antiviral activity of cyclopentenone prostanoids
155. 2 is regulated at two separate levels and is associated with induction of stress protein synthesis
156. Prostaglandin A inhibits the replication of vesicular stomatitis virus: Effect on virus glycoprotein
157. Inhibition of virus protein glycosylation as the mechanism of the antiviral action of prostaglandin A in Sendai virus-infected cells
158. A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter
159. Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation
160. Protein-DNA interactions within DNase I-hypersensitive sites located downstream of the HIV-1 promoter
161. NF-κB-mediated chromatin reconfiguration and transcriptional activation of the HIV-1 enhancer in vitro
162. Histone acetyltransferases regulate HIV-1 enhancer activity in vitro